维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="Herrstedt"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Pre'~ention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia international antiemetic consensus conference 显示文摘	ROILA F HESKETH PJ HERRSTEDT J	2006	Ann Oncol2006，17，1：	1
2	Antiemetic efficacy of the neurokinin-1antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid inpatients receiving anthracyclines or cyclophosphamide in addition to highdosecisplatin: analysis of combineddata from two Phase III randomizedclinical trials显示文摘	Gralla RJ1 de Wit R Herrstedt J	2005	Cancer2005，104，4：	1
3	ESMO minimum clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)显示文摘	Herrstedt J Aapro MS Roila F	2005	Ann On col2005，16，1：	1
4	Antiemetics: an update and the MASCC guidelines applied in clinical practice显示文摘	Herrstedt J	2008	Nat Clin Pract O ncol2008，，：	1
5	Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting显示文摘	Ruhlmann CH Herrstedt J	2011	Expert Opin Drug Saf2011，10，3：	1
6	Chemotherapy-induced nausea and -~omiting: ESMO clinical recommendations for prophylaxis 显示文摘	Herrstedt J Roila F ESMO Guidelines Working Group	2009	Ann Oncol2009，20，4：	1
7	A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small cell lung cancer显示文摘	Sorensen M Jensen PB Herrstedt J	2001	Ann Oncol2001，11，7：	1
8	Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference显示文摘	Roila F Herrstedt J Aapro M	2010	Ann Oncol2010，21，5：	1
9	Prevention of chemotherapy- and radiotherapy - induced emesis: results of the 2004 Perngia International Antiemetic Consensus Con- ference显示文摘	Roila F Hesketh P J Herrstedt J	2006	Ann Oncol2006，17，：	1
10	Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy- induced nausea and vomiting: results of the Perugia consensus onference显示文摘	Roila F Herrstedt J Aapro M	2010	Ann Oncol2010，215，：	1
11	Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference显示文摘	Roila F Herrstedt J Aapro M	2010	Ann Oncol2010，21，5：	1
12	Prognostic value of Musashi-1 in gliomas显示文摘	Dahlrot RH Hansen S Herrstedt J		0，，03：	1
13	Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting:results of the Perugia consensus conference显示文摘	Roila F Herrstedt J Aapro M	2010	Ann Oncol2010，21，5：	1
14	Prevention of chemotherapy- and radiotherapy-induced emesis : results of the 2004 Perugia In- ternational Antiemetic Consensus Conference 显示文摘	Roila F Hesketh PJ Herrstedt J	2006	Ann Oncol2006，17，1：	1
15	Antiemetic effi- cacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiv- ing anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials显示文摘	Gralla R J De Wit R Herrstedt J	2005	Cancer2005，104，4：	1
16	Chemotherapy-induced nausea and vomiting : ES- MO clinical recommendations for prophylaxis显示文摘	Herrstedt J Roila F	2009	Ann Oncol2009，20，4：	1
17	Addition of the oral NK1 antagonist aprepitant to standard antiemet- ics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy 显示文摘	De Wit R Herrstedt J Rapoport B	2003	J Clin Oncol2003，21，22：	1
18	Antiemetics: an update and the MASCC guidelines applied in clinical practice显示文摘	Herrstedt J	2008	Nat Clin Pract Oncol2008，5，1：	1
19	Fosaprepitant for the preven-tion of chemotherapy-induced nausea and vomiting显示文摘	RUHLMANN CH HERRSTEDT J	2012	Expert RevAnticancer Ther2012，12，2：	1
20	The oral NK (1) antagonist, aprepitant, given with standard antiemet- ics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-con- trolled phase III clinical trials显示文摘	De Wit R Herrstedt J Rapoport B	2004	Eur J Cancer2004，40，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示